Localisation of basic fibroblast growth factor in cholesteatoma matrix: An immunochemical study

M. A. Hamed, R. H. Sayed, Kazuya Shiogama, M. A. Eltaher, K. Suzuki, S. Nakata

Research output: Contribution to journalArticle

Abstract

Objective: To investigate the expression of basic fibroblast growth factor in the matrix of human acquired cholesteatoma compared to the deep meatal skin. This topic does not appear to have been fully investigated before. Methods: An immunochemical study was conducted. Cholesteatoma tissues from adult patients were collected during surgery (n = 19). Control specimens were taken from the deep meatal skin (n = 8) and compared. Results: A highly significant difference in basic fibroblast growth factor expression was identified between cholesteatoma and skin (mean ± standard error = 58.53 ± 3.6 per cent in cholesteatoma vs 40.6 ± 3.5 per cent in skin; p = 0.005). Both basal and parabasal keratinocytes were stained positive with basic fibroblast growth factor. Additionally, there was specific staining in the basal columnar middle-ear epithelium and mast cell membrane. Conclusion: Basic fibroblast growth factor plays an active role in proliferative activity of cholesteatoma through its overexpression in basal and parabasal layers of cholesteatoma matrix. Moreover, its expression in the mast cell membrane supports its role in bone resorption activity.

Original languageEnglish
Pages (from-to)183-186
Number of pages4
JournalJournal of Laryngology and Otology
Volume133
Issue number3
DOIs
Publication statusPublished - 01-03-2019

Fingerprint

Cholesteatoma
Fibroblast Growth Factor 2
Skin
Mast Cells
Cell Membrane
Middle Ear
Bone Resorption
Keratinocytes
Epithelium
Staining and Labeling

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Hamed, M. A. ; Sayed, R. H. ; Shiogama, Kazuya ; Eltaher, M. A. ; Suzuki, K. ; Nakata, S. / Localisation of basic fibroblast growth factor in cholesteatoma matrix : An immunochemical study. In: Journal of Laryngology and Otology. 2019 ; Vol. 133, No. 3. pp. 183-186.
@article{92ef3a69d4fa4ca3885054fa8e121868,
title = "Localisation of basic fibroblast growth factor in cholesteatoma matrix: An immunochemical study",
abstract = "Objective: To investigate the expression of basic fibroblast growth factor in the matrix of human acquired cholesteatoma compared to the deep meatal skin. This topic does not appear to have been fully investigated before. Methods: An immunochemical study was conducted. Cholesteatoma tissues from adult patients were collected during surgery (n = 19). Control specimens were taken from the deep meatal skin (n = 8) and compared. Results: A highly significant difference in basic fibroblast growth factor expression was identified between cholesteatoma and skin (mean ± standard error = 58.53 ± 3.6 per cent in cholesteatoma vs 40.6 ± 3.5 per cent in skin; p = 0.005). Both basal and parabasal keratinocytes were stained positive with basic fibroblast growth factor. Additionally, there was specific staining in the basal columnar middle-ear epithelium and mast cell membrane. Conclusion: Basic fibroblast growth factor plays an active role in proliferative activity of cholesteatoma through its overexpression in basal and parabasal layers of cholesteatoma matrix. Moreover, its expression in the mast cell membrane supports its role in bone resorption activity.",
author = "Hamed, {M. A.} and Sayed, {R. H.} and Kazuya Shiogama and Eltaher, {M. A.} and K. Suzuki and S. Nakata",
year = "2019",
month = "3",
day = "1",
doi = "10.1017/S0022215119000112",
language = "English",
volume = "133",
pages = "183--186",
journal = "Journal of Laryngology and Otology",
issn = "0022-2151",
publisher = "Cambridge University Press",
number = "3",

}

Localisation of basic fibroblast growth factor in cholesteatoma matrix : An immunochemical study. / Hamed, M. A.; Sayed, R. H.; Shiogama, Kazuya; Eltaher, M. A.; Suzuki, K.; Nakata, S.

In: Journal of Laryngology and Otology, Vol. 133, No. 3, 01.03.2019, p. 183-186.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Localisation of basic fibroblast growth factor in cholesteatoma matrix

T2 - An immunochemical study

AU - Hamed, M. A.

AU - Sayed, R. H.

AU - Shiogama, Kazuya

AU - Eltaher, M. A.

AU - Suzuki, K.

AU - Nakata, S.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Objective: To investigate the expression of basic fibroblast growth factor in the matrix of human acquired cholesteatoma compared to the deep meatal skin. This topic does not appear to have been fully investigated before. Methods: An immunochemical study was conducted. Cholesteatoma tissues from adult patients were collected during surgery (n = 19). Control specimens were taken from the deep meatal skin (n = 8) and compared. Results: A highly significant difference in basic fibroblast growth factor expression was identified between cholesteatoma and skin (mean ± standard error = 58.53 ± 3.6 per cent in cholesteatoma vs 40.6 ± 3.5 per cent in skin; p = 0.005). Both basal and parabasal keratinocytes were stained positive with basic fibroblast growth factor. Additionally, there was specific staining in the basal columnar middle-ear epithelium and mast cell membrane. Conclusion: Basic fibroblast growth factor plays an active role in proliferative activity of cholesteatoma through its overexpression in basal and parabasal layers of cholesteatoma matrix. Moreover, its expression in the mast cell membrane supports its role in bone resorption activity.

AB - Objective: To investigate the expression of basic fibroblast growth factor in the matrix of human acquired cholesteatoma compared to the deep meatal skin. This topic does not appear to have been fully investigated before. Methods: An immunochemical study was conducted. Cholesteatoma tissues from adult patients were collected during surgery (n = 19). Control specimens were taken from the deep meatal skin (n = 8) and compared. Results: A highly significant difference in basic fibroblast growth factor expression was identified between cholesteatoma and skin (mean ± standard error = 58.53 ± 3.6 per cent in cholesteatoma vs 40.6 ± 3.5 per cent in skin; p = 0.005). Both basal and parabasal keratinocytes were stained positive with basic fibroblast growth factor. Additionally, there was specific staining in the basal columnar middle-ear epithelium and mast cell membrane. Conclusion: Basic fibroblast growth factor plays an active role in proliferative activity of cholesteatoma through its overexpression in basal and parabasal layers of cholesteatoma matrix. Moreover, its expression in the mast cell membrane supports its role in bone resorption activity.

UR - http://www.scopus.com/inward/record.url?scp=85062293397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062293397&partnerID=8YFLogxK

U2 - 10.1017/S0022215119000112

DO - 10.1017/S0022215119000112

M3 - Article

AN - SCOPUS:85062293397

VL - 133

SP - 183

EP - 186

JO - Journal of Laryngology and Otology

JF - Journal of Laryngology and Otology

SN - 0022-2151

IS - 3

ER -